Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 109,424 | 122,061 | 226,751 | 585,578 | 134,036 |
| Marketable Securities | 219,301 | 194,332 | 225,443 | 70,831 | 559,822 |
| Receivables | 93,471 | 91,105 | 92,103 | 96,318 | 49,975 |
| Inventories | 96,799 | 100,588 | 103,662 | 98,550 | 67,209 |
| TOTAL | $533,411 | $526,210 | $667,018 | $866,048 | $822,352 |
| Non-Current Assets | |||||
| PPE Net | 193,646 | 191,279 | 189,767 | 188,401 | 159,235 |
| Investments And Advances | 17,394 | 0 | 0 | 0 | 21,192 |
| Intangibles | 738,363 | 741,456 | 755,368 | 769,143 | 190,168 |
| Other Non-Current Assets | 251,551 | 275,043 | 279,323 | 251,761 | 163,055 |
| TOTAL | $1,200,954 | $1,207,778 | $1,224,458 | $1,209,305 | $533,650 |
| Total Assets | $1,734,365 | $1,733,988 | $1,891,476 | $2,075,353 | $1,356,002 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 33,872 | 33,776 | 33,680 | 24,234 | N/A |
| Accounts payable and accrued liabilities | 12,933 | 13,983 | 14,843 | 10,543 | 7,895 |
| Accrued Expenses | 76,357 | 77,275 | 87,669 | 127,555 | 50,798 |
| Other current liabilities | N/A | N/A | N/A | N/A | 5,070 |
| TOTAL | $131,526 | $133,179 | $305,073 | $521,118 | $225,788 |
| Non-Current Liabilities | |||||
| Long Term Debt | 309,848 | 318,344 | 326,828 | 335,263 | N/A |
| Other Non-Current Liabilities | 522,868 | 525,829 | 539,874 | 488,564 | 411,612 |
| TOTAL | $832,716 | $844,173 | $876,827 | $823,827 | $411,612 |
| Total Liabilities | $964,242 | $977,352 | $1,181,900 | $1,344,945 | $637,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,882 | 45,824 | 45,437 | 44,848 | 44,544 |
| Common Shares | 46 | 46 | 45 | 45 | 45 |
| Retained earnings | -138,649 | -137,956 | -157,832 | -211,895 | -206,765 |
| Other shareholders' equity | -670 | -605 | -527 | 167 | 153 |
| TOTAL | $770,123 | $756,636 | $709,576 | $730,408 | $718,602 |
| Total Liabilities And Equity | $1,734,365 | $1,733,988 | $1,891,476 | $2,075,353 | $1,356,002 |